Christobel Selecky Receives Stock Award at ImmunityBio Inc (IBRX) — SEC Form 4, Jun 11, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
TXN 2026-06-09 · FILED 2026-06-11
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-06-11
Report Date
2026-06-11
Accession No.
0001849739-26-000007
Accepted At
2026-06-11 00:11 UTC
Reporting Owner
Name Relationship
Christobel Selecky CIK 0001849739
Director
Christobel Selecky at ImmunityBio Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $2,997,932
More from this insider at ImmunityBio Inc
2026-07-07 Sell -$1,439,066 View
2026-07-01 Sell -$871,216 View
2026-02-25 Sell -$250,000 View
2026-01-22 Sell -$437,650 View
2025-06-20 Award — View
All filings by this insider at ImmunityBio Inc
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Stock Option (right to buy)F1 $7.25 2026-06-09 A - Award/Grant 65,600 A $0.00 2036-06-09 65,600 Common Stock Direct
Footnotes (1)
F1
Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders. Show more
5%+ Holders · 13D/G 1 filer
Other insiders at ImmunityBio Inc
All ImmunityBio Inc insider activity
GET /v1/forms/4/0001849739-26-000007 API docs
View Original SEC Filing